Congratulation on two winning 22nd National Innovation Awards

Congratulations!

This Thursday (12/18), at the 22nd National Innovation Awards Ceremony, the highest honor in Taiwan's biomedical industry, Oncogen.AI, led by founder Prof. Sandy, Cheng-Yu Chen, was awarded the Clinical Innovation Award for two groundbreaking systems:

• AI Radiology Reporting Agent (iReport)
• Molecular Tumor Board AI Agent System (Mira)

Both products underwent a rigorous three-stage review process by the jury, who recognized their innovative value and practical applications. This is a tremendous recognition for
OncogenAI, and we extend our heartfelt gratitude to Taipei Medical University and Taipei Medical University Hospital for their support and collaboration.

We will continue to push forward innovation, enhance its value, and create a new chapter in precise cancer care and clinical workflows!